AKAN

Akanda Corp. operates as an international cannabis company focused on cultivating, processing, and distributing medical cannabis products in emerging markets. Headquartered in London, United Kingdom, the company maintains cultivation and processing operations primarily in Lesotho, Southern Africa, through its subsidiary Bophelo Bioscience & Wellness. Akanda operates a 147-acre cultivation campus in Lesotho that holds licenses for cannabis cultivation, manufacturing, and exports. The company targets European and African medical cannabis markets, positioning itself as a low-cost producer leveraging Lesotho's favorable climate and regulatory environment for cannabis cultivation. Akanda's business model centers on supplying medical-grade cannabis flower and extracts to international markets where medical cannabis is legal. The company holds Good Manufacturing Practice (GMP) certification, enabling it to supply pharmaceutical-grade products to regulated markets. In recent years, Akanda has focused on establishing distribution partnerships in Europe and expanding its production capabilities in Africa. The company went public through a merger with a special purpose acquisition company in 2021, listing on Nasdaq. Akanda continues to develop its cultivation infrastructure and pursue market access agreements with distributors and pharmaceutical partners across its target regions, while navigating the evolving regulatory landscape for medical cannabis in international markets.